Literature DB >> 29614305

Could Fecal Transplantation Become Part of PD-1-Based Immunotherapy, Due to Effects of the Intestinal Microbiome?

Paolo Biancheri1, Devina Divekar1, Alastair J M Watson1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29614305     DOI： 10.1053/j.gastro.2018.03.060

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

Review 1.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

Review 2.  Microbiome diurnal rhythmicity and its impact on host physiology and disease risk.

Authors:  Samuel Philip Nobs; Timur Tuganbaev; Eran Elinav
Journal:  EMBO Rep       Date:  2019-03-15       Impact factor: 8.807

3.  Esterases From Bifidobacteria Exhibit the Conversion of Albiflorin in Gut Microbiota.

Authors:  Ran Peng; Pei Han; Jie Fu; Zheng-Wei Zhang; Shu-Rong Ma; Li-Bin Pan; Yuan-Yuan Xia; Hang Yu; Hui Xu; Chang-Xiao Liu; Yan Wang
Journal:  Front Microbiol       Date:  2022-04-06       Impact factor: 6.064

Review 4.  The Gut Microbiota and Respiratory Diseases: New Evidence.

Authors:  Li Chunxi; Liu Haiyue; Lin Yanxia; Pan Jianbing; Su Jin
Journal:  J Immunol Res       Date:  2020-07-31       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.